What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Callan JMB Announces Pricing of $5.12 Million Initial Public Offering

Callan JMB Announces Pricing of $5.12 Million Initial Public Offering

SPRING BRANCH, Texas, Feb. 04, 2025 (GLOBE NEWSWIRE) — Callan JMB Inc. (NASDAQ: CJMB) (“Callan” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced the pricing of its initial public offering (the “Offering”) of 1,280,000 shares (the “Shares”) of common stock (“Common Stock”) at an initial public offering price of $4.00 per Share for a total of approximately $5,120,000 of gross proceeds to the Company before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. In addition, Callan has granted the underwriters a 45-day option to purchase, at the public offering price, up to an additional 192,000 shares of Common Stock at the public offering price, less the underwriting discounts and commissions. Read More >

Coldchain Technology Services, a CALLAN JMB, Inc Company

Coldchain Technology Services, a CALLAN JMB, Inc Company News & Announcements

Callan JMB provides top-level pharmaceutical logistics services through its distribution company, Coldchain Technology Services (CTS), with operations in Texas, Illinois, and Oregon. CTS excels in the cGMP storage and distribution of time- and temperature-sensitive products including vaccines and therapeutics, with distributor licenses in most states, DSCSA and FDA compliance, and a proprietary Inventory Management System capable of tracking pinpoint shipments and producing instant reports on inventory quantities, shipment status, and compliance data. Callan JMB provides the gold standard in cold chain shippers and in remote monitoring of storage temperatures for hospitals, pharmacies, and 503B compounders.  We are working to reduce the effects of drug shortages by sourcing APIs and finished products from other countries and providing the logistics to bring them to the U.S. Callan JMB is committed to protecting the efficacy of products at all stages for patient safety and wellness.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Callan JMB Announces Pricing of $5.12 Million Initial Public Offering

Name
Address
Subscribe